Welcome

Vaccine Hesitancy Down in U.S., But 1 in 7 Are Still Reluctant

April 14, 2021, 6:34 PM

Vaccine hesitancy in the U.S. is shrinking, though 1 in 7 residents remain wary about getting a Covid-19 vaccine, largely because of concerns about side effects.

That segment is younger and less educated than average, according to a tracker released Wednesday by the U.S. Census Bureau that uses Household Pulse Survey data. Residents were surveyed before U.S. regulators on Tuesday recommended pausing Johnson & Johnson vaccines because of concerns about rare blood clots.

Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses the pause in the rollout of Johnson & Johnson’s Covid-19 vaccine.
Source: Bloomberg)

Hesitancy is one of the final hurdles that health officials face on the path to herd immunity. Rapidly spreading variants are increasing pressure on the Biden ...



To read the full article log in.

Learn more about a Bloomberg Law subscription.